SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027755
Filing Date
2021-11-10
Accepted
2021-11-10 08:00:37
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1034324
2 ex10-1.htm EX-10.1 92133
3 ex31-1.htm EX-31.1 18301
4 ex31-2.htm EX-31.2 18320
5 ex32-1.htm EX-32.1 6385
6 ex32-2.htm EX-32.2 6415
7 ex10-1_001.jpg GRAPHIC 2439
  Complete submission text file 0001493152-21-027755.txt   5439957

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE lixt-20210930.xsd EX-101.SCH 45541
9 XBRL CALCULATION FILE lixt-20210930_cal.xml EX-101.CAL 33379
10 XBRL DEFINITION FILE lixt-20210930_def.xml EX-101.DEF 230480
11 XBRL LABEL FILE lixt-20210930_lab.xml EX-101.LAB 366614
12 XBRL PRESENTATION FILE lixt-20210930_pre.xml EX-101.PRE 281798
13 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 807002
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39717 | Film No.: 211394476
SIC: 2834 Pharmaceutical Preparations